Biologic Abatement and Capturing Kids’ Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA): study protocol for a randomized pragmatic trial

Biologic Abatement and Capturing Kids’ Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA): study protocol for a randomized pragmatic trial

Abstract Background The effectiveness of biologic therapies, primarily tumor necrosis factor inhibitors (TNFi), for children with spondyloarthritis (SpA) has made inactive disease a realistic patient outcome. However, biologic therapies are costly, primarily delivered by subcutaneous or intravenous...

Descripció completa

Dades bibliogràfiques
Autors principals: Pamela F. Weiss, Cora E. Sears, Timothy G. Brandon, Christopher B. Forrest, Emily Neu, Melanie Kohlheim, Jenny Leal, Rui Xiao, Daniel Lovell
Format: Article
Idioma:English
Publicat: BMC 2023-02-01
Col·lecció:Trials
Matèries:
Spondyloarthritis
Pediatrics
Biologic
Randomized pragmatic trial
Electronic Health Records
Patient-reported outcome
Accés en línia:https://doi.org/10.1186/s13063-022-07038-6

Internet

https://doi.org/10.1186/s13063-022-07038-6

Ítems similars